Adaptation and Implementation of the "Kidney Disease: Improving Global Outcomes (KDIGO)" Guidelines for Evaluation and Management of Mineral and Bone Disorders in Chronic Kidney Disease for Practice in the Middle East Countries
Adaptation and Implementation of the "Kidney Disease: Improving Global Outcomes (KDIGO)" Guidelines for Evaluation and Management of Mineral and Bone Disorders in Chronic Kidney Disease for Practice in the Middle East Countries
复制标题
DOI：
10.4103/1319-2442.124536
复制
发表时间：
2014-01-01
影响因子：
0.5
通讯作者：
Shaheen, Faissal A. M.
中科院分区：
文献类型：
--
作者：
Al Rukhaimi, Mona;Al Sahow, Ali;Shaheen, Faissal A. M.
本综述介绍了中东肾脏病专家专家组和国际专家对 2009 年肾脏病：改善全球成果 (KDIGO) 评估和管理慢性肾脏病矿物质和骨骼疾病 (CKD-MBD) 指南在中东国家实践的适应和实施的观点。小组成员审查了 KDIGO 指南，并制定了可在中东 CKDMBD 管理中实际实施的建议。 KDIGO 工作组提出的大部分建议得到了广泛的认同。然而，小组成员对特定领域进行了评论，并阐述了可能对中东肾脏病学家有所帮助的某些概念。最终文件由所有参与者以及 KDIGO 指南中东工作组实施小组的成员进行了审查。他们的意见被纳入。指南陈述连同详细的理由和相关讨论以及证据的局限性一起提出。专家组认识到需要将 KDIGO 与 CKD 3-5D 期患者的侧腹部 X 光片和超声心动图相关的建议升级为更强的建议。专家组强调了 CKD-MBD 的高磷血症风险，以及肾移植后骨活检、骨病评估和治疗的相关建议。
This review presents the views of an expert group of nephrologists from the Middle East along with an international expert on adaptation and implementation of the 2009 Kidney Disease: Improving Global Outcomes (KDIGO) guidelines for evaluation and management of mineral and bone disorders in chronic kidney disease (CKD-MBD) for practice in the Middle East countries. The members of the panel examined the KDIGO guidelines and formulated recommendations that can be implemented practically for the management of CKDMBD in the Middle East. There was a broad agreement on most of the recommendations made by the KDIGO work-group. However, the panelists commented on specific areas and amplified certain concepts that might help the nephrologists in the Middle East. The final document was reviewed by all participants as well as by members of the Middle East task force implementation group for KDIGO guidelines. Their comments were incorporated. The guideline statements are presented along with detailed rationale and relevant discussion as well as limitations of the evidence. The panel recognized the need to upgrade the suggestion of KDIGO related to lateral abdominal radiograph and echocardiogram in patients with CKD stages 3-5D into a stronger recommendation. The panel underlined the risk of hyper-phosphatemia to CKD-MBD and the imtions concerning bone biopsy, evaluation and treatment of bone disease after kidney transplantation should be implemented as such.